Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.430
+0.020 (0.59%)
At close: Aug 6, 2026, 4:00 PM EDT
3.470
+0.040 (1.17%)
After-hours: Aug 6, 2026, 7:59 PM EDT
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $116.7 million as of August 6, 2026. Its market cap has increased by 14.97% in one year.
Market Cap
116.70M
Enterprise Value
102.53M
1-Year Change
14.97%
Ranking
Category
Stock Price
$3.43
ChartMarket Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $116.70M, an increase of 40.26%. That is a compound annual growth rate of 1.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 116.70M | 13.63% |
| Dec 31, 2025 | 102.70M | 37.48% |
| Dec 31, 2024 | 74.70M | -38.06% |
| Dec 29, 2023 | 120.60M | -7.44% |
| Dec 30, 2022 | 130.30M | 46.40% |
| Dec 31, 2021 | 89.00M | 21.92% |
| Dec 31, 2020 | 73.00M | 10.11% |
| Dec 31, 2019 | 66.30M | -10.04% |
| Dec 31, 2018 | 73.70M | 106.44% |
| Dec 29, 2017 | 35.70M | -24.52% |
| Dec 30, 2016 | 47.30M | 79.85% |
| Dec 31, 2015 | 26.30M | 10.04% |
| Dec 31, 2014 | 23.90M | -39.34% |
| Dec 31, 2013 | 39.40M | 18.32% |
| Dec 31, 2012 | 33.30M | 73.44% |
| Dec 30, 2011 | 19.20M | -39.81% |
| Dec 31, 2010 | 31.90M | -65.14% |
| Dec 31, 2009 | 91.50M | 61.95% |
| Dec 31, 2008 | 56.50M | -63.00% |
| Dec 31, 2007 | 152.70M | 62.27% |
| Dec 29, 2006 | 94.10M | 31.24% |
| Dec 30, 2005 | 71.70M | -0.42% |
| Dec 31, 2004 | 72.00M | 94.07% |
| Dec 31, 2003 | 37.10M | 183.21% |
| Dec 31, 2002 | 13.10M | -52.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 132.54M |
| NRx Pharmaceuticals | 130.76M |
| Codexis | 129.98M |
| Spruce Biosciences | 128.28M |
| enGene Therapeutics | 122.59M |
| ProMIS Neurosciences | 120.88M |
| Seer, Inc. | 119.58M |
| Nautilus Biotechnology | 119.06M |